Vaccine studies in Uganda: Site preparation, infrastructure development, and capacity building for clinical trials.
Focal Person: Dr Tom Egwang/ Prof Olobo
Donors: World Bank / G.O.U

Correlating protection against malaria with serum profiles against Plasmodium falciparum antigen repertoires
Focal Person: Dr Tom Egwang
Donors: EU

Single blind, randomized, controlled, phase 1b study of the safety and immunogenicity of lyophilized recombinant precipitated tropical vaccine (BK-SE36) in Uganda
Focal Person: Dr Tom Egwang/ Prof Toshi Horii
Donors: BIKEN

Molecular markers for cassava
Focal Person: Dr Elizabeth Kizito
Donors: BioEarn

Design, produce, and undertake preclinical evaluation of Novel second-generation malaria vaccines
Focal Person: Dr Tom Egwang/ Prof Olobo
Donors: World bank/GOU

Bioprospecting from genomes for type II restriction enzymes
Focal Person: Dr Tom Egwang
Donors: New England Biolabs USA